PCR fluorescence
-
28 ʻAno o ka Human Papilloma Virus kiʻekiʻe (16/18 Typing) Nucleic Acid
He kūpono kēia pahu no ka ʻike ʻana i ka qualitative in vitro o 28 mau ʻano o nā maʻi papilloma kanaka (HPV) (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) nucleic acid i loko o ka mimi kāne/wahine a me nā pūnaewele exfoliated cervical wahine. Hiki ke ʻano ʻia ka HPV 16/18, ʻaʻole hiki ke ʻano ʻia nā ʻano i koe, e hāʻawi ana i kahi ala kōkua no ka ʻike ʻana a me ka mālama ʻana i ka maʻi HPV.
-
28 ʻAno o ka HPV Nucleic Acid
Hoʻohana ʻia ke kime no ka ʻike ʻana i ka qualitative in vitro o 28 mau ʻano o nā human papillomaviruses (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) nucleic acid i loko o ka mimi kāne/wahine a me nā pūnaewele exfoliated cervical wahine, akā ʻaʻole hiki ke ʻano piha ʻia ka maʻi.
-
Ke ʻano o ka hoʻohālikelike ʻana o ka maʻi papilloma kanaka (28 ʻano)
Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ka qualitative a me ka genotyping o ka nucleic acid o 28 mau ʻano o ka human papillomavirus (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) i loko o ka mimi kāne/wahine a me nā pūnaewele exfoliated cervical wahine, e hāʻawi ana i nā mea kōkua no ka ʻike a me ka mālama ʻana i ka maʻi HPV.
-
ʻO ka Enterococcus kū'ē i ka Vancomycin a me ka Gene kū'ē i ka lāʻau lapaʻau
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka vancomycin-resistant enterococcus (VRE) a me kāna mau genes kūʻē i nā lāʻau lapaʻau ʻo VanA a me VanB i loko o ka sputum kanaka, ke koko, ka mimi a i ʻole nā kolone maʻemaʻe.
-
ʻO ka Polymorphism Gene CYP2C9 kanaka a me VKORC1
He kūpono kēia pahu hana no ka ʻike ʻana i ka polymorphism o CYP2C9*3 (rs1057910, 1075A>C) a me VKORC1 (rs9923231, -1639G>A) ma ka DNA genomic o nā hāpana koko holoʻokoʻa kanaka.
-
ʻO ka Polymorphism Gene CYP2C19 kanaka
Hoʻohana ʻia kēia pahu no ka ʻike qualitative in vitro o ka polymorphism o nā genes CYP2C19 CYP2C19*2 (rs4244285, c.681G>A), CYP2C19*3 (rs4986893, c.636G>A), CYP2C19*17 (rs12248560, c.806>T) i loko o ka genomic DNA o nā hāpana koko holoʻokoʻa kanaka.
-
ʻAkika Nucleic B27 Leukocyte kanaka
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka DNA ma nā ʻano antigen leukocyte kanaka HLA-B*2702, HLA-B*2704 a me HLA-B*2705.
-
ʻO ka maʻi Monkeypox Nucleic Acid
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative in vitro o ka nucleic acid monkeypox virus i loko o ka wai ʻulaʻula kanaka, nā swabs nasopharyngeal, nā swabs ʻāʻī a me nā laʻana serum.
-
ʻO ka waikawa nukleika Ureaplasma Urealyticum
He kūpono kēia pahu hana no ka ʻike ʻana i ka Ureaplasma urealyticum (UU) i loko o nā ʻāpana mimi kāne a me nā ʻāpana hoʻohemo o nā ʻāpana genital wahine ma vitro.
-
ʻO ka waikawa nukleika polymorphic gene MTHFR
Hoʻohana ʻia kēia pahu hana e ʻike i nā wahi mutation 2 o ka gene MTHFR. Hoʻohana ka pahu hana i ke koko holoʻokoʻa kanaka ma ke ʻano he laʻana hoʻāʻo e hāʻawi i kahi loiloi qualitative o ke kūlana mutation. Hiki iā ia ke kōkua i nā kauka lapaʻau e hoʻolālā i nā hoʻolālā lapaʻau kūpono no nā ʻano pilikino like ʻole mai ka pae molekala, i mea e hōʻoia ai i ke olakino o nā maʻi i ka nui loa.
-
Ka Hoʻololi ʻana o ka Gene BRAF Kanaka V600E
Hoʻohana ʻia kēia pahu hoʻāʻo e ʻike pono i ka mutation BRAF gene V600E i loko o nā hāpana ʻiʻo i hoʻokomo ʻia me ka paraffin o ka melanoma kanaka, ka maʻi ʻaʻai colorectal, ka maʻi ʻaʻai thyroid a me ka maʻi ʻaʻai māmā in vitro.
-
Ka Hoʻololi ʻana o ke Kino Hoʻohuihui BCR-ABL Kanaka
He kūpono kēia pahu hana no ka ʻike ʻana i ka qualitative o nā isoforms p190, p210 a me p230 o ka gene fusion BCR-ABL i loko o nā hāpana iwi kanaka.
